References
- Donev R, Gantert D, Alawam K, et al. Comorbidity of schizophrenia and adult attention-deficit hyperactivity disorder. World J. Biol Psychiatry 2011;12(Suppl 1):52-6
- Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med 2005;2:e141
- WHO. The global burden of disease, 2004 Update. WHO, Geneva, Switzerland; 2008. www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf [Last accessed 12 March 2013]
- Wu E, Birnbaum H, Ball D, et al. The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatr 2005;66(9):1122-9
- Lambert TJ, Velakoulis D, Pantelis C. Medical comorbidity in schizophrenia. Med J Aust 2003;178(Suppl):S67-70
- Kilbourne AM, Brar JS, Drayer RA, et al. Cardiovascular disease and metabolic risk factors. Psychosomatics 2007;48:412-17
- Strassnig M, Brar JS, Ganguli R. Self-reported body weight perception and dieting practices in community-dwelling patients with schizophrenia. Schizophr Res 2005;75(2-3):425-32
- Hartz SM, Pato CN, Medeiros H, et al. Comorbidity of severe psychotics disorders with measures of substance use. JAMA Psychiatry 2014. [Epub ahead of print]
- Druss BG, Bradford DW, Rosenheck RA, et al. Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA 2000;283(4):506-11
- Craddock-O’Leary J, Young AS, Yano EM, et al. Use of general medical services by VA patients with psychiatric disorders. Psychiatr Serv 2002;53(7):874-8
- Desai MM, Rosenheck RA, Druss BG, et al. Mental disorders and quality of diabetes care in the Veterans Health Administration. Am J Psychiatry 2002;159(9):1584-90
- Newcomer JW. Metabolic disturbances associated with antipsychotic use. J Clin Psychiatry 2001;62(Suppl 27):3-4
- Jeste DV, Gladsjo JA, Lindamer LA, et al. Medical comorbidity in schizophrenia. Schizophr Bull 1996;22(3):413-30
- Lambert TJ, Velakoulis D, Pantelis C. Medical comorbidity in schizophrenia. Med J Aust 2003;178(Suppl):S67-70
- Buckley PF, Miller BJ, Lehrer DS, et al. Psychiatric comorbidities and schizophrenia. Schizophr Bull 2009;35(2):383-402
- Koranyi EK. Morbidity and rate of undiagnosed physical illnesses in a psychiatric clinic population. Arch Gen Psychiatry 1979;36(4):414-19
- Hall RC, Gardner ER, Popkin MK, et al. Unrecognized physical illness prompting psychiatric admission: a prospective study. Am J Psychiatry 1981;138(5):629-35
- Koran LM, Sox HC Jr, Marton KI, et al. Medical evaluation of psychiatric patients. I. Results in a state mental health system. Arch Gen Psychiatry 1989;46(8):733-40
- Carney P, Jone L, Woolson R. Medical comorbidity in women and men with schizophrenia: a population-based controlled study. J Gen Intern Med 2006;21(11):1133-7
- Lyketsos CG, Dunn G, Kaminsky MJ, et al. Medical comorbidity in psychiatric inpatients: relation to clinical outcomes and hospital length of stay. Psychosomatics 2002;43(1):24-30
- Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat 1985;39(33):38
- D’Agostino RB. Tutorial in biostatistics: propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-81
- Mooney CZ, Duval RD. Bootstrapping: a nonparametric approach to statistical inference. Sage Publications; Newbury Park, CA, USA: 1993
- Amiel JM, Pincus HA. The medical home model: new opportunities for psychiatric services in the United States. Curr Opin Psychiatry 2011;24(6):562-8
- Dworkin RH. Pain insensitivity in schizophrenia: a neglected phenomenon and some implications. Schizophr Bull 1994;20(2):235-48
- Brown S, Birtwistle J, Roe L, et al. The unhealthy lifestyle of people with schizophrenia. Psychol Med 1999;29(3):697-701
- Valenstein M, Blow F, Copeland L, et al. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophr Bull 2004;30(2):255-64
- Masand PS, Roca M, Turner MS, et al. Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review. Prim Care Companion J Clin Psychiatry 2009;11(4):147-54
- Hennekens CH, Hennekens AR, Hollar D, et al. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005;150(6):1115-21
- Hennekens CH. Increasing global burden of cardiovascular disease in general populations and patients with schizophrenia. J Clin Psychiatry 2007;68(Suppl 4):4-7
- Osby U, Correia N, Brandt L, et al. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res 2000;45(1-2):21-8
- Meltzer HY, Alphs L, Green AI, et al. Clozapine treatment for suicidality in schizophrenia. Arch Gen Psychiatry 2003;60(1):82-91
- Rothbard AB, Metraux S, Blank MB. Cost of care for Medicaid recipients with serious mental illness and HIV infection or AIDS. Psychiatr Serv 2003;54(9):1240-6
- Rothbard AB, Miller K, Lee S, et al. Revised cost estimates of Medicaid recipients with serious mental illness and HIV-AIDS. Psychiatr Serv 2009;60(7):974-7
- Chwastiak LA, Rosenheck RA, McEvoy JP. The impact of obesity on health care costs among persons with schizophrenia. Gen Hosp Psychiatry 2009;31(1):1-7